Cargando…
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
BACKGROUND: Histone acetylation is an epigenetic modification involved in the regulation of gene expression, balanced by histone acetyl transferases and histone deacetylase (HDAC) enzymes. HDAC inhibitors (HDACi) induce growth arrest and cell death in transformed cells, and are currently in many cli...
Autores principales: | Dejligbjerg, Marielle, Grauslund, Morten, Litman, Thomas, Collins, Laura, Qian, Xiaozhong, Jeffers, Michael, Lichenstein, Henri, Jensen, Peter Buhl, Sehested, Maxwell |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553797/ https://www.ncbi.nlm.nih.gov/pubmed/18789133 http://dx.doi.org/10.1186/1476-4598-7-70 |
Ejemplares similares
-
Monitoring the effect of belinostat in solid tumors by H4 acetylation
por: MARQUARD, LENA, et al.
Publicado: (2008) -
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells
por: Jensen, Lars H, et al.
Publicado: (2004) -
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
por: Buckley, Michael T, et al.
Publicado: (2007) -
Chromatin Remodeling, Cell Proliferation and Cell Death in Valproic Acid-Treated HeLa Cells
por: Felisbino, Marina Barreto, et al.
Publicado: (2011) -
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours
por: Lassen, U, et al.
Publicado: (2010)